7C01
Molecular basis for a potent human neutralizing antibody targeting SARS-CoV-2 RBD
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | SSRF BEAMLINE BL17U1 |
| Synchrotron site | SSRF |
| Beamline | BL17U1 |
| Temperature [K] | 100 |
| Detector technology | PIXEL |
| Collection date | 2020-03-22 |
| Detector | DECTRIS EIGER X 16M |
| Wavelength(s) | 0.97919 |
| Spacegroup name | P 21 21 21 |
| Unit cell lengths | 87.400, 106.730, 170.590 |
| Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
| Resolution | 34.830 - 2.880 |
| R-factor | 0.2204 |
| Rwork | 0.218 |
| R-free | 0.26510 |
| Structure solution method | MOLECULAR REPLACEMENT |
| Starting model (for MR) | 6lgz 4tsa |
| RMSD bond length | 0.004 |
| RMSD bond angle | 0.776 |
| Data reduction software | HKL-2000 |
| Data scaling software | HKL-2000 |
| Phasing software | PHASER |
| Refinement software | PHENIX (1.15.2_3472) |
Data quality characteristics
| Overall | Outer shell | |
| Low resolution limit [Å] | 50.000 | 2.950 |
| High resolution limit [Å] | 2.880 | 2.880 |
| Number of reflections | 36863 | 2670 |
| <I/σ(I)> | 12.2 | |
| Completeness [%] | 99.9 | |
| Redundancy | 13 | |
| CC(1/2) | 0.997 | 0.640 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION, SITTING DROP | 291 | 24 % w/v PEG 1500, 20 % v/v Glycerol |






